ArticleDiagnostics (Basel, Switzerland)2023

Targeted Genomic Profiling and Chemotherapy Outcomes in Grade 3 Gastro-Entero-Pancreatic Neuroendocrine Tumors (G3 GEP-NET).

Giuseppe Lamberti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.